UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045144
Receipt number R000051508
Scientific Title Observational study on breast cancer detection using autoantibodies against the antigen of cancer stem cells
Date of disclosure of the study information 2021/08/13
Last modified on 2021/08/12 19:53:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational study on breast cancer detection using autoantibodies against the antigen of cancer stem cells

Acronym

Autoantibodies for Breast Cancer Detection (ABCD study)

Scientific Title

Observational study on breast cancer detection using autoantibodies against the antigen of cancer stem cells

Scientific Title:Acronym

Autoantibodies for Breast Cancer Detection (ABCD study)

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to measure the levels of autoantibodies against cancer stem cell antigens found in the peripheral blood of breast cancer patients and to analyze their ability to detect breast cancer.

Basic objectives2

Others

Basic objectives -Others

Correct diagnosis rate, sensitivity, and specificity of autoantibody titer for diagnosis of the presence of breast cancer.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Correct diagnosis rate, sensitivity, and specificity of autoantibody titer for diagnosis of the presence of breast cancer.

Key secondary outcomes

Correlation of autoantibody titer with imaging findings, clinicopathological findings, immunohistological findings, tumor markers, stage, and history of breast cancer
Changes in autoantibody titer before and after treatment
Correlation between each autoantibody titer
Correlation between autoantibody titer and incidence of postoperative recurrence and prognosis


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who have been diagnosed with breast cancer by cytological or pathological diagnosis.
Patients who have obtained the written consent of their own free will with sufficient understanding after receiving sufficient explanation for participation in this study.

Key exclusion criteria

History and comorbidity of malignant or autoimmune diseases
Use of steroids (oral) or immunosuppressive drugs
Patients deemed unsuitable as subjects by the principal investigator

Target sample size

350


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Kyuno

Organization

Sapporo Medical University

Division name

Department of Pathology and Department of Surgery, Surgical Oncology and Science

Zip code

060-8556

Address

South-1, West-17, Chuo-ku, Sapporo 060-8556, Japan

TEL

0116112111

Email

kyuno@sapmed.ac.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Kyuno

Organization

Sapporo Medical University

Division name

Department of Pathology and Department of Surgery, Surgical Oncology and Science

Zip code

060-8556

Address

South-1, West-17, Chuo-ku, Sapporo 060-8556, Japan

TEL

0116112111

Homepage URL


Email

kyuno@sapmed.ac.jp


Sponsor or person

Institute

Sapporo Medical University

Institute

Department

Personal name



Funding Source

Organization

Japan Surgical Society

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)

Northern Advancement Center for Science and Technology


IRB Contact (For public release)

Organization

IRB, Sapporo Medical University Hospital

Address

South-1, West-16, Chuo-ku, Sapporo 060-8556, Japan

Tel

011-611-2111

Email

ji-rskk@sapmed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 08 Month 13 Day

Date of IRB

2020 Year 08 Month 13 Day

Anticipated trial start date

2020 Year 11 Month 05 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Study Design
Observational study in breast cancer patients (cross-sectional study)
Eligible patients
Patients with breast cancer attending or hospitalized in the Department of Surgery, Surgical Oncology and Science, Sapporo Medical University
The planned number of patients will be 300 patients with breast cancer, and 50 patients with benign diseases will be set as the control group.


Management information

Registered date

2021 Year 08 Month 12 Day

Last modified on

2021 Year 08 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051508


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name